These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Conductors on a one-way track: do medical authorities really get to decide policy about medical screening tests? Peticolas A MedGenMed; 2003 May; 5(2):5. PubMed ID: 14603104 [No Abstract] [Full Text] [Related]
43. Unresolved issues in controlling the tuberculosis epidemic among the foreign-born in the United States. Weber GS Am J Law Med; 1996; 22(4):503-36. PubMed ID: 9006668 [No Abstract] [Full Text] [Related]
44. Children's behavioral health screening. Herman M NCSL Legisbrief; 2004; 12(24):1-2. PubMed ID: 15112682 [No Abstract] [Full Text] [Related]
45. [Iatrogenic injuries of the accessory nerve]. Pásztor E Orv Hetil; 1996 Dec; 137(48):2714. PubMed ID: 9679604 [No Abstract] [Full Text] [Related]
46. The issue of failure to communicate the findings of a medical examination versus breach of confidentiality in prostate cancer screening. Frank-Stromborg M; Gerard M Clin J Oncol Nurs; 1999 Apr; 3(2):75-6, 84. PubMed ID: 10633615 [No Abstract] [Full Text] [Related]
49. Clinical laboratory health screening tests: a regulatory case study. Gordon L Clin Leadersh Manag Rev; 2001; 15(3):179-82. PubMed ID: 11392702 [No Abstract] [Full Text] [Related]
50. Advantages and disadvantages of population screening for cancer and surveillance of at-risk groups. Craanen ME; Kuipers EJ Best Pract Res Clin Gastroenterol; 2001 Apr; 15(2):211-26. PubMed ID: 11355912 [TBL] [Abstract][Full Text] [Related]
52. Radiation from bomb tests could cause thyroid cancer, but screening program not advisable. US National Academy Press. J Radiol Prot; 1998 Dec; 18(4):303-4. PubMed ID: 9915646 [No Abstract] [Full Text] [Related]
53. [Management and its criterion of iatrogenic blood vessel injuries]. Wu QH Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(3):148-9. PubMed ID: 17498365 [No Abstract] [Full Text] [Related]
55. [Doctors are increasingly held liable for missed diagnosis of cancer in mass screening]. De Rijke JM; Schouten LJ Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1764. PubMed ID: 11572181 [No Abstract] [Full Text] [Related]
56. Industry opposes genomic legislation. Chahine K Nat Biotechnol; 2002 May; 20(5):419. PubMed ID: 11981541 [No Abstract] [Full Text] [Related]
57. Medicaid requirements for state programs of early and periodic screening, diagnosis, and treatment of individuals under 21: final regulation. Fed Regist; 1979 May; 44(98):29419-27. PubMed ID: 10297458 [No Abstract] [Full Text] [Related]
58. [The essence of the Law on Population Screening]. Gebhardt DO Ned Tijdschr Geneeskd; 1996 Nov; 140(44):2203. PubMed ID: 8984360 [No Abstract] [Full Text] [Related]
59. [The essence of the Law on Population Screening]. ten Kate LP Ned Tijdschr Geneeskd; 1996 Nov; 140(44):2203-4. PubMed ID: 8984361 [No Abstract] [Full Text] [Related]
60. [Law on Mass Screening]. Gevers JK Ned Tijdschr Geneeskd; 1994 Apr; 138(14):729-31. PubMed ID: 8152516 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]